https://clinicaltrials.gov/ct2/show/NCT04292730?cond=remdesivir&draw=2&rank=6
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
https://clinicaltrials.gov/ct2/show/NCT04292899?cond=remdesivir&draw=2&rank=5
